BGF sells OrganOx to Terumo Corporation for $1.5bn

OrganOx is an Oxford-based medtech company.

27 August 2025•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals UK Western Europe Healthcare Briefs